Future Medicinal Chemistry cited on ISI
Future Medicinal Chemistry accepted for coverage on ISI
Future Science Ltd announced today that its journal Future Medicinal Chemistry (ISSN 1756-8919) has been selected for coverage in ISI. The ISI Web of Knowledge is published by Thomson Reuters and incorporates the Science Citation Index Expanded as well as the Social Sciences Citation Index and more.
Future Medicinal Chemistry is published monthly in print and online formats on a rapid publication basis, with articles subject to peer review by at least three independent assessors. The journal has international expert authorship and offers review articles, drug profiles, editorials, technology reports, interviews, perspectives and a variety of added-value content.
Elisa Manzotti, Editorial Director of the Future Science series commented, “We are delighted that Future Medicinal Chemistry has been accepted for inclusion and it is now our intention to work with the Editors of the journal to ensure that future issues keep pace with the huge amount of research being generated within the field.” She continued “We would like to thank our Editorial Board for their hard work, intellectual input and guidance in targeting and evaluating topical, pioneering content to ensure inclusion of the journal on ISI.
Manzotti further commented that, “…the Future Science series, our latest imprint, is already making an impact with an impressive list of citations over our range of titles. I am absolutely delighted that Future Medicinal Chemistry has been recognized by ISI, with more Future Science titles coming up over the year, we are very positive going ahead.
Also accepted for inclusion on ISI was Expert Review of Neurotherapeutics published by Expert Reviews Ltd, a sister imprint of Future Science, which also operates under the Future Science Group banner.
The ISI Web of Knowledge is searchable for free at www.isiknowledge.com
Access to Future Medicinal Chemistry is available via a free 30-day trial. To apply for your free trial please email email@example.com quoting reference FMCISI10 to obtain password access.